Maurilio de Souza Cazarim

Pharmacist, Ph.D. professor at the Federal University of Juiz de Fora (UFJF), Juiz de Fora-MG, Brazil (2019). Postdoctoral Fellow in Public Health at the Ribeirão Preto Medical School, University of São Paulo (FMRP/USP) (ongoing). Permanent Professor of the Graduate Program in Nursing (PPGEn) at UFJF (2023). Member of the Health Technology Assessment Center of the University Hospital at UFJF and the Ribeirão Preto Clinical Hospital (NATS HU-UFJF and NATS HCFMRP-USP) (2023). Associate Editor of the Brazilian Journal of Health and Pharmacy (BJHP) (2023). Advisory member of the UFJF Research Evaluation Committee (2022). Member of the Research Ethics Committee at the University Hospital of UFJF (2022). PROADI - SUS technical consultant for the process of implementation of pharmaceutical care in Brazilian municipalities, 2019. BSc. (2010) at Federal University of Juiz de Fora, scientific initiation scholarship holder, which has contemplated researches related to pharmaceutical services and drug utilization study. Specialist in public health and clinical pharmacy (2013) by the Holistic Health Care Program - Medical School of Ribeirão Preto, University of São Paulo (Multidisciplinary Residency), Integrative care totaling 6 thousand hour of specialization, worked on Primary (60), Secondary (20), Tertiary (20) care. FAPESP scholarship for the master degree,, Pharmaceutical Sciences - Pharmacoeconomics and clinical pharmacy (2016) from Faculty of Pharmaceutical Sciences of Ribeirão Preto / University of São Paulo (FCFRP / USP), research about Pharmacoeconomics and Clinical Pharmacy. P.hD. Graduate Pharmaceutical Sciences program of the Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (FCFRP / USP), in 2019. The thesis is related to health economics area - pharmacoeconomics with further study pharmacoeconomic analysis for Health Technology Assessment and clinical pharmacy area. This research is about development and validation of a pharmacoeconomic tool. Along this research has been able to development systematic review, clinical trials, epidemiological and validation studies and also techinics about modeling applications and sensitivities analysis for Health Technology Assessment (HTA), in highlight Pharmaceutical Care. Sandwich University of Glasgow, at the Health Economics Health Technology Assessment (HEHTA), under the supervision of Professor Olivia Wu, scholarship BEPE / FAPESP, where was able developed skills in five pharmacoeconomics sub-areas (modeling; health technology assessment in global context, survival analysis, data analysis for health economics, applicability of pharmacoeconomic studies and MCDA analyzes). (Source: Lattes Curriculum)